WT1 and cancer: Other work in vitro analyzed that the 17AA (-)/KTS (-) WT1 isoform modulates the expression of cytoskeletal regulatory proteins such as α-actinin 1, cofilin, and gelsolin, allowing cancer cells to acquire a more aggressive phenotype [50].